These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 1557658)
1. Biochemical modulation of fluorouracil by dipyridamole: preclinical and clinical experience. Grem JL Semin Oncol; 1992 Apr; 19(2 Suppl 3):56-65. PubMed ID: 1557658 [TBL] [Abstract][Full Text] [Related]
2. Alteration of fluorouracil metabolism in human colon cancer cells by dipyridamole with a selective increase in fluorodeoxyuridine monophosphate levels. Grem JL; Fischer PH Cancer Res; 1986 Dec; 46(12 Pt 1):6191-9. PubMed ID: 2946402 [TBL] [Abstract][Full Text] [Related]
3. Interaction of deoxyuridine with fluorouracil and dipyridamole in a human colon cancer cell line. Grem JL; Mulcahy RT; Miller EM; Allegra CJ; Fischer PH Biochem Pharmacol; 1989 Jan; 38(1):51-9. PubMed ID: 2462882 [TBL] [Abstract][Full Text] [Related]
4. Augmentation of 5-fluorouracil cytotoxicity in human colon cancer cells by dipyridamole. Grem JL; Fischer PH Cancer Res; 1985 Jul; 45(7):2967-72. PubMed ID: 4005834 [TBL] [Abstract][Full Text] [Related]
5. 5-Fluoropyrimidine-induced DNA damage in human colon adenocarcinoma and its augmentation by the nucleoside transport inhibitor dipyridamole. Lönn U; Lönn S; Nylen U; Winblad G Cancer Res; 1989 Mar; 49(5):1085-9. PubMed ID: 2521812 [TBL] [Abstract][Full Text] [Related]
6. Azidothymidine and dipyridamole as biochemical response modifiers: synergism with methotrexate and 5-fluorouracil in human colon and pancreatic carcinoma cells. Zhen YS; Taniki T; Weber G Oncol Res; 1992; 4(2):73-8. PubMed ID: 1596584 [TBL] [Abstract][Full Text] [Related]
7. Dipyridamole potentiates the growth-inhibitory action of methotrexate and 5-fluorouracil in human keratinocytes in vitro. Schwartz PM; Milstone LM J Invest Dermatol; 1989 Oct; 93(4):523-7. PubMed ID: 2476512 [TBL] [Abstract][Full Text] [Related]
8. Effect of folinic acid on fluorouracil activity and expression of thymidylate synthase. van der Wilt CL; Pinedo HM; Smid K; Cloos J; Noordhuis P; Peters GJ Semin Oncol; 1992 Apr; 19(2 Suppl 3):16-25. PubMed ID: 1532671 [TBL] [Abstract][Full Text] [Related]
9. Biochemical modulation of 5-fluorouracil with or without leucovorin by a low dose of brequinar in MGH-U1 cells. Chen TL; Erlichman C Cancer Chemother Pharmacol; 1992; 30(5):370-6. PubMed ID: 1380407 [TBL] [Abstract][Full Text] [Related]
10. Determinants of cytotoxicity with prolonged exposure to fluorouracil in human colon cancer cells. Ren Q; Van Groeningen CJ; Hardcastle A; Aherne GW; Geoffroy F; Allegra CJ; Johnston PG; Grem JL Oncol Res; 1997; 9(2):77-88. PubMed ID: 9167189 [TBL] [Abstract][Full Text] [Related]
11. Modulation of 5-fluorouracil toxicity by uridine, deoxyuridine, orotate and dipyridamole in normal tissues of rats with liver adenocarcinoma. el Hag IA; Jakobsson B; Christensson PI; Erichsen C; Jönsson PE; Stenram U In Vivo; 1987; 1(5):309-12. PubMed ID: 2485133 [TBL] [Abstract][Full Text] [Related]
12. Resistance of a human ovarian cancer line to 5-fluorouracil associated with decreased levels of 5-fluorouracil in DNA. Chu E; Lai GM; Zinn S; Allegra CJ Mol Pharmacol; 1990 Sep; 38(3):410-7. PubMed ID: 2402230 [TBL] [Abstract][Full Text] [Related]
13. Biochemical modulation of fluorouracil with leucovorin and interferon: preclinical and clinical investigations. Grem JL; Chu E; Boarman D; Balis FM; Murphy RF; McAtee N; Allegra CJ Semin Oncol; 1992 Apr; 19(2 Suppl 3):36-44. PubMed ID: 1557656 [TBL] [Abstract][Full Text] [Related]
14. Rate-limiting steps in the interactions of fluoropyrimidines and methotrexate. Bowen D; Bailey BD; Guernsey LA Eur J Cancer Clin Oncol; 1984 May; 20(5):651-7. PubMed ID: 6234172 [TBL] [Abstract][Full Text] [Related]
15. Modulation of 5-fluorouracil and 5-fluorouridine toxicity by membrane transport inhibitors in normal tissues of rats with liver adenocarcinoma. Jakobsson B; el Hag IA; Erichsen C; Christensson PI; Jönsson PE; Stenram U Anticancer Res; 1989; 9(2):285-90. PubMed ID: 2751255 [TBL] [Abstract][Full Text] [Related]
16. Differentially potentiating effects by dipyridamole on cytotoxicity of 5-fluorouracil against three human maxillary cancer cell lines derived from a single tumor. Sato S; Kohno K; Hidaka K; Hisatsugu T; Kuwano M; Komiyama S Anticancer Drug Des; 1993 Aug; 8(4):289-97. PubMed ID: 8240657 [TBL] [Abstract][Full Text] [Related]
17. Interaction of gamma interferon and 5-fluorouracil in the H630 human colon carcinoma cell line. Chu E; Zinn S; Boarman D; Allegra CJ Cancer Res; 1990 Sep; 50(18):5834-40. PubMed ID: 1697502 [TBL] [Abstract][Full Text] [Related]
18. Augmentation of 5-fluoro-2'-deoxyuridine cytotoxicity by 5-phenethyl-2'-deoxyuridine in human gastric cancer cells in culture. Tokuzen R; Yamaguchi T; Saneyoshi M; Yoshida M; Maeda M Anticancer Drugs; 1994 Aug; 5(4):419-23. PubMed ID: 7949245 [TBL] [Abstract][Full Text] [Related]
19. Mechanism of cell death following thymidylate synthase inhibition: 2'-deoxyuridine-5'-triphosphate accumulation, DNA damage, and growth inhibition following exposure to CB3717 and dipyridamole. Curtin NJ; Harris AL; Aherne GW Cancer Res; 1991 May; 51(9):2346-52. PubMed ID: 2015598 [TBL] [Abstract][Full Text] [Related]
20. [Modulation of the biochemical effect of 5-fluorouracil (5-FU) by leucovorin measured by thymidylate synthase activity and nucleoside incorporation into DNA]. Kau B; Rieger M; Sauer H Onkologie; 1990 Dec; 13(6):453-7. PubMed ID: 2092282 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]